Ningxia Taikang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Ningxia Dadi Circular Development Co., Ltd., with an area of 1,067,200 square meters, a fixed asset of CNY 674 million and a total installed capacity of 160,000 KVA. As one of the 40 large-scale industrial backbone enterprises in the Ningxia Hui Autonomous Region, our company now has more than 1,100 employees, including 134 main management personnel, 112 professional and technical personnel, 5 senior engineers, 10 engineers, 3 economists and 15 technicians. At present, our nnual production capacity: pharmaceutical intermediates- Dicyandiamide 6WT, Cyanamide 5,000T, Creatine monohydrate 3,000T, Aminoguanidine bicarbonate 3,000T; Chemical basic materials-Calcium Cyanamide 22.5WT, Calcium Carbide 12WT.
Now, our daily production is relying on the steam heat energy and power supply of Ningxia Tianrui Heat Energy Supply Company (a company of our parent company) and the CO2 tail gas of Ningxia Kunhui Gasification Company, and all production waste residues are sent to the production project of the Ningxia Kunshui Cement Company as raw materials. At the same time, all our production water is internally recycled and used. Therefore, our company has successfully become a recycling, energy-saving and environment-friendly enterprise with zero pollution and zero emission.
As the largest Dicyandiamide production base in the world, our production capacity accounts for more than 60% of the Chinese market share and over 70% of the global market share. The enterprise standard (Q/NXTK001-2019) of our main product-Dicyandiamide is superior to the current national standard (HG/T 3264-1999) of China, and the registered trademarks of our company are "Dadi" and "Taikang" brand. At present, the qualities of all our products have reached the national standards of high-grade products, and our products are well sold in China and more than 30 countries and regions such as the United States, the European Union, Brazil, India, Japan and South Korea, etc.